secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001829126-26-003240
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZEO ScientifiX selected as qualified team for XPRIZE Healthspan $101M competition semi-finals
--------------------------------------------------------------------------------

- Advancing to semi-finals of XPRIZE Healthspan; aims to develop therapeutics restoring muscle, cognitive, and immune function by 10-20 years in persons aged 65-80.
- Assembled multidisciplinary team: Dr. Shapiro (CMO), Elizabeth Parrish (BioViva), Dr. Andrews (telomere biology), Dr. Kennedy (Buck Institute), and others.
- Focus on extracellular vesicle (exosome) therapeutics and next-generation delivery systems targeting aging and inflammation biology.
- Company operates labs at Nova Southeastern University; recently appointed as A4M regenerative medicine educational partner.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912626003240/0001829126-26-003240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912626003240/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-003240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer